Enzyme kinetics questions are the biochem version of “every word matters.” The vignette will look like it’s about a drug or a mutation, but what they’re really testing is whether you can translate a scenario into changes in and —and whether you can spot why each tempting distractor is wrong.
Tag: Biochemistry > Amino Acids & Enzymes
The Q-bank-style vignette
A 6-year-old boy is evaluated for recurrent kidney stones and photosensitivity. Labs show elevated urinary porphobilinogen and -aminolevulinic acid. Genetic testing reveals decreased activity of an enzyme in heme synthesis due to a missense mutation. In vitro enzyme kinetics are performed comparing patient enzyme to wild type. The patient enzyme shows a lower maximal reaction rate but the substrate concentration required to reach half-maximal velocity is unchanged.
Which of the following best describes the kinetic changes?
A. Increased , unchanged
B. Decreased , unchanged
C. Unchanged , decreased
D. Unchanged , increased
E. Decreased , decreased
Step-by-step: translate the stem into kinetics
The stem basically hands you the definitions:
- “Lower maximal reaction rate” decreased
- “Substrate concentration required to reach half-maximal velocity is unchanged” unchanged (because is the at )
So the correct choice is:
✅ Correct answer: C. Unchanged , decreased
Why this happens (the mechanism they’re aiming for)
A missense mutation that reduces enzyme activity often behaves like having less functional enzyme (or a lower catalytic rate), rather than altering substrate binding.
High-yield mapping:
- depends on enzyme amount and catalytic capacity:
- If the enzyme is dysfunctional or effectively reduced in functional concentration, falls.
- reflects affinity (roughly):
- Lower = higher apparent affinity
- Higher = lower apparent affinity
- If binding is unchanged, stays the same.
Clinically, “enzyme deficiency” questions commonly imply decreased (less working enzyme), not necessarily a binding defect.
The visual: Lineweaver–Burk and Michaelis–Menten quick cues
Key landmarks
- On a Lineweaver–Burk plot:
- -intercept =
- -intercept =
- slope =
What this vignette would show
- Decreased higher -intercept ( increases)
- Unchanged same -intercept
Systematically destroying the distractors (why every answer choice matters)
A. Increased , unchanged ❌
This pattern screams competitive inhibition (or decreased substrate affinity with intact catalytic machinery).
- Competitive inhibitor:
- increases
- does not change
- can be overcome by high substrate concentrations
Why it’s wrong here:
- The stem explicitly says half-max substrate is unchanged unchanged.
- And it says max rate is lower decreased.
USMLE hook: If the stem mentions a drug that resembles substrate (e.g., methotrexate vs folate; statins vs HMG-CoA), think competitive: , same .
B. Decreased , unchanged ❌
This would mean increased apparent affinity without changing maximal capacity—uncommon as a simple disease mutation vignette.
Where you might see decreased :
- An enzyme engineered or mutated to bind substrate more tightly (rarely tested clinically)
- Certain allosteric activation concepts (though Step questions usually avoid forcing true Michaelis–Menten parameters onto allosteric enzymes)
Why it’s wrong here:
- The stem states is lower, not unchanged.
High-yield pearl: Don’t over-interpret “mutation” as “higher affinity.” Most pathogenic enzyme mutations reduce function (often lowering ).
C. Unchanged , decreased ✅
Matches exactly.
Classic causes:
- Noncompetitive inhibition (pure): inhibitor binds enzyme and ES equally well
- Decreased enzyme concentration (or functional enzyme)
- Catalytic defect: reduced with preserved binding
Common USMLE phrasing that maps here:
- “Decreased quantity of enzyme”
- “Enzyme inactivated”
- “Mutation decreases catalytic activity but not binding”
D. Unchanged , increased ❌
This is basically “more effective enzyme capacity.”
What can raise ?
- Increased enzyme concentration (induction)
- Increased (rare)
- Removing an inhibitor (in an experimental setup)
Why it’s wrong here:
- The stem explicitly says lower maximal rate, not higher.
Test strategy: When a question offers “increased ,” look for language like “enzyme induction,” “upregulated expression,” or “increased enzyme concentration.” Absent that, it’s usually bait.
E. Decreased , decreased ❌
This combination can be seen with uncompetitive inhibition (inhibitor binds only ES), which shifts both parameters down.
Uncompetitive inhibitor:
- decreases
- decreases
- parallel Lineweaver–Burk lines (slope unchanged because stays constant)
Why it’s wrong here:
- The stem says unchanged, not decreased.
USMLE hook: Uncompetitive inhibition shows up when they emphasize binding to ES complex only, and it becomes more effective at higher substrate concentrations (because more ES exists).
High-yield kinetics cheat sheet (memorize this table)
| Situation | Lineweaver–Burk hallmark | ||
|---|---|---|---|
| Competitive inhibition | — | Same -int, -int moves toward 0 | |
| Noncompetitive (pure) | — | Same -int, -int increases | |
| Uncompetitive inhibition | Parallel lines | ||
| Increased enzyme concentration | — | -int decreases | |
| Decreased functional enzyme (loss-of-function) | usually — | -int increases |
Remember: In classic Michaelis–Menten questions, if binding changes, changes. If capacity changes, changes.
Mini-clinical tie-in: why the stem mentions heme synthesis at all
The porphyria flavor text is there to make it feel clinical, but the kinetics question stands on its own. Still, Step exams love bridging:
- Many inborn errors reduce effective enzyme activity (less functional enzyme)
- That commonly presents kinetically as decreased
- Unless the stem explicitly hints at altered binding/affinity, assume is unchanged
Exam-day approach (fast and reliable)
- Circle “half-max velocity substrate concentration” clue
- Circle “max rate” or “plateau” clue
- Ask: is this a binding problem (affinity) or a capacity problem (amount/function)?
- Match to inhibitor patterns only if the stem describes an inhibitor-like scenario.